Contribution of CMV-specific T cells to chronic kidney rejection
CMV 特异性 T 细胞对慢性肾排斥反应的影响
基本信息
- 批准号:10054619
- 负责人:
- 金额:$ 15.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-08 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAddressAdultAffectAgeAgingAntibodiesAntiviral AgentsArchivesBiological AssayBiopsyBiopsy SpecimenBloodCD8-Positive T-LymphocytesCell AgingCellsCharacteristicsChromatinChronicClinicalCollaborationsComplicationComputer AnalysisControl GroupsCore FacilityCytomegalovirusCytomegalovirus InfectionsDataData AnalysesData SetDetectionDevelopmentDiagnosisElderlyEnd stage renal failureEnvironmentExposure toFeasibility StudiesFlow CytometryFrequenciesGene Expression ProfilingGenerationsGoalsGraft SurvivalHealthImaging TechniquesImmuneImmune responseImmunityImmunosuppressionImpairmentIncidenceIndividualInfectionInfiltrationInflammationInflammatoryKidneyKidney DiseasesKidney TransplantationKnowledgeLearningLengthLifeMaintenanceMeasuresMediatingMicroscopyMorbidity - disease rateOpportunistic InfectionsOrgan TransplantationOutcomePathogenicityPathologistPatientsPeptidesPeripheral Blood Mononuclear CellPhenotypePopulationPredispositionProcessProductionProphylactic treatmentProteinsRenal Cell CarcinomaResearchResearch PersonnelRiskRoleSamplingSavingsScientistSignal TransductionSiteSorting - Cell MovementStainsSurfaceSymptomsT memory cellT-LymphocyteTestingTimeTrainingTransplant RecipientsTransplantationViralViremiaVirus LatencyVirus Replicationagedaging populationbasecareercell agecohortcomplex data cytokinecytotoxiccytotoxicityexperienceimmunosenescenceimprovedindexinginnovationkidney allograftkidney biopsykidney dysfunctionmacrophagemortalitymortality risknovel diagnosticsnovel therapeuticspost-transplantpost-transplant diseaseprematurereceptorresponsesenescenceseropositivesingle-cell RNA sequencingtelomeretranscription factor
项目摘要
Project Summary
Kidney transplantation is life-saving for people with end stage kidney disease (ESKD). However, complications
including opportunistic infection and chronic T cell- and antibody-mediated rejection reduce long-term graft
survival. Seropositivity for cytomegalovirus (CMV) is associated with higher rates of chronic rejection after
transplantation. Chronic exposure to CMV induces immunosenescence in CMV-responsive memory T cells,
including loss of proliferative capacity and differentiation potential, with maintained production of inflammatory
cytokines. In consequence, these cells become less protective, and may even promote rejection. My
preliminary data suggest that the development of senescence in response to CMV is accelerated after
transplantation. In addition, T cell mediated infiltration of inflammatory macrophages into kidney grafts can
induce rejection. Macrophages are a major site of CMV infection. Together, these observations led to the
hypothesis that senescent CMV-responsive T cells contribute to chronic rejection that will be tested
through two aims. The goal of the first aim is to characterize senescence in CMV-responsive T cells post-
transplant. CMV-responsive T cells will be analyzed at post-transplant time points before and after the onset of
acceleration of senescence. Characterization will include in-depth gene expression profiling by single cell RNA
sequencing and functional assays for chromatin accessibility, telomere length, and proliferation. The goal of
the second aim is to determine whether CMV-responsive T cells and inflammatory macrophages influence
susceptibility to chronic rejection. Quantity and localization of infiltration of both CMV-specific T cells and
macrophages into kidney allografts will be measured in archived biopsy specimens, comparing patients
diagnosed with chronic rejection to a control group of patients with chronicity. Phenotypic analysis of blood T
cells at the time of transplant biopsy will identify populations correlated with rejection, which in the long-term
may provide a new diagnostic of rejection. The career plan is for the PI to become an independent investigator
researching the effects of immune complications on kidney transplant. The research environment at Stanford is
well suited for these studies, given access to core facilities for sequencing, flow cytometry, and microscopy.
The aims provide opportunities to gain expertise in collaboration with bioinformaticians, statisticians,
nephrologists, and pathologists, which are key to the career plan. Specifically, Aim 1 involves collaboration with
Dr. Purvesh Khatri for complex data analysis of sequencing data sets. Aim 2 involves collaboration with
transplant nephrologists Drs Jane Tan and Paul Grimm and pathologist Dr. Neeraja Kambham for analysis and
interpretation of biopsy results. It also involves collaboration with renal cell carcinoma researcher Dr. Wendy
Fantl and statistician Dr. Robert Tibshirani for highly multiplexed analysis of biopsy specimens. These aims are
formulated to gain understanding of the role of CMV-responsive T cells in chronic rejection, potentially to
produce new therapies to chronic rejection, and to support the applicant’s transition to independence.
项目概要
肾移植对于终末期肾病 (ESKD) 患者来说可以挽救生命。然而,并发症
包括机会性感染以及慢性 T 细胞和抗体介导的排斥反应,减少长期移植物
生存。巨细胞病毒(CMV)血清阳性与术后慢性排斥反应的较高发生率相关。
移植。长期接触 CMV 会诱导 CMV 反应性记忆 T 细胞发生免疫衰老,
包括增殖能力和分化潜力的丧失,同时维持炎症的产生
细胞因子。结果,这些细胞的保护作用减弱,甚至可能促进排斥反应。我的
初步数据表明,CMV 反应后衰老的发展加速。
移植。此外,T细胞介导的炎症巨噬细胞浸润至肾移植物中可以
诱发排斥反应。巨噬细胞是CMV感染的主要部位。这些观察结果共同导致了
衰老的 CMV 反应性 T 细胞会导致慢性排斥反应的假设将得到测试
通过两个目标。第一个目标是表征 CMV 反应性 T 细胞的衰老特征
移植。 CMV 反应性 T 细胞将在移植后时间点进行分析
加速衰老。表征将包括单细胞 RNA 的深入基因表达谱分析
染色质可及性、端粒长度和增殖的测序和功能测定。目标是
第二个目的是确定 CMV 反应性 T 细胞和炎症巨噬细胞是否影响
对慢性排斥反应的易感性。 CMV 特异性 T 细胞和 CMV 特异性 T 细胞浸润的数量和定位
将在存档的活检标本中测量进入同种异体肾移植物的巨噬细胞,以比较患者
诊断为慢性排斥反应的对照组为慢性排斥反应患者。血T表型分析
移植活检时的细胞将识别与排斥相关的群体,从长远来看
可能会提供新的排斥反应诊断。 PI的职业规划是成为一名独立调查员
研究免疫并发症对肾移植的影响。斯坦福大学的研究环境是
非常适合这些研究,可以使用测序、流式细胞术和显微镜的核心设施。
这些目标提供了与生物信息学家、统计学家合作获得专业知识的机会,
肾病学家和病理学家,这是职业规划的关键。具体来说,目标 1 涉及与
Purvesh Khatri 博士负责测序数据集的复杂数据分析。目标 2 涉及与
移植肾病专家 Jane Tan 博士和 Paul Grimm 博士以及病理学家 Neeraja Kambham 博士进行分析和
活检结果的解释。它还涉及与肾细胞癌研究人员 Wendy 博士的合作
Fantl 和统计学家 Robert Tibshirani 博士对活检标本进行了高度多重分析。这些目标是
旨在了解 CMV 反应性 T 细胞在慢性排斥反应中的作用,可能有助于
开发针对慢性排斥的新疗法,并支持申请人向独立过渡。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lauren Higdon其他文献
Lauren Higdon的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lauren Higdon', 18)}}的其他基金
Contribution of CMV-specific T cells to chronic kidney rejection
CMV 特异性 T 细胞对慢性肾排斥反应的影响
- 批准号:
10398912 - 财政年份:2020
- 资助金额:
$ 15.41万 - 项目类别:
Contribution of CMV-specific T cells to chronic kidney rejection
CMV 特异性 T 细胞对慢性肾排斥反应的影响
- 批准号:
10213023 - 财政年份:2020
- 资助金额:
$ 15.41万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 15.41万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 15.41万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 15.41万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 15.41万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 15.41万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 15.41万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 15.41万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 15.41万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 15.41万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 15.41万 - 项目类别:
Research Grant